Novel Treatments for Neuromuscular Disorders

Flex Pharma, Inc. is a biotechnology company that is developing innovative and proprietary treatments for cramps and spasms associated with the severe neurological diseases of ALS, MS and peripheral neuropathies such as Charcot-Marie-Tooth (CMT). 


October 16, 2017 Flex Pharma Initiates CMT Phase 2 Trial with FLX-787 in US
Read More

September 6, 2017 Flex Pharma Presenting at Upcoming Investor Conferences in September 2017
Read More